(1)
The Efficacy and Toxicity of Programs MOPP, ABVD, BEACOPP-Base in Primary Hodgkin’s Lymphoma Patients With a Poor Prognosis. Вопр. онкол. 2013, 59 (2), 59-65. https://doi.org/10.37469/0507-3758-2013-59-2-59-65.